BioPharm International-02-01-2008

Two case studies illustrate a systematic approach.

Columns and Departments

February 01, 2008

The much needed modernization of the agency's IT systems and inspection capabilities will likely fall prey to budget shortfalls.

Columns and Departments

February 01, 2008

The use of disposables has changed significantly in the biopharmaceutical industry.

Columns and Departments

February 01, 2008

Both innovator and generics companies are using analytics to support comparability arguments.

Columns and Departments

February 01, 2008

In our increasingly global industry; foreign manufacturing inspections are more important than ever.

Best practices from Big Biotech, including how to handle new product introductions.

Columns and Departments

February 01, 2008

The key to a good graphical presentation is to select the method that best fits the data.

Columns and Departments

February 01, 2008

Indian biogenerics could form a major piece of the global biotherapeutics market in the future.

Putting business principles to work in biotechs requires careful implementation of nine critical business systems.